Mirion has been initiated with an Outperform rating and $26 price target by Northland. The radiation technology company has a presence in 95% of the global nuclear reactor fleet and is exposed to attractive end markets of nuclear power and medicine. The firm believes Mirion's mix of recurring revenue and growth upside allows investors to benefit from both.
Mirion Technologies, Inc. (MIR) has been initiated with an Outperform rating and a $26 price target by Northland. The radiation technology company has a significant presence in 95% of the global nuclear reactor fleet and is exposed to attractive end markets of nuclear power and medicine. The firm believes Mirion's mix of recurring revenue and growth upside allows investors to benefit from both.
Mirion Technologies has earned a Growth Score of B and a Zacks Rank #2, indicating strong growth prospects and positive earnings estimate revisions. The company's earnings growth is expected to be 22% this year, which is significantly higher than the industry average of 20.7%. Additionally, Mirion's year-over-year cash flow growth is 5.3%, which is higher than the industry average of -10.3%. Over the past 3-5 years, the company's annualized cash flow growth rate has been 1360.6%, compared to the industry average of 13.8% [1].
Moreover, the current-year earnings estimates for Mirion Technologies have been revising upward, with the Zacks Consensus Estimate surging 5% over the past month. This positive trend suggests that the company's financial performance is improving, which could lead to near-term stock price movements [1].
Mirion Technologies' strong growth prospects, favorable financial metrics, and positive earnings estimate revisions make it a potential outperformer and a solid choice for growth investors. The company's exposure to attractive end markets and its mix of recurring revenue and growth upside further enhance its appeal to investors.
References:
[1] https://www.nasdaq.com/articles/mirion-technologies-mir-solid-growth-stock-3-reasons-think-yes
Comments
No comments yet